Kunin C M, Dobbins J J, Melo J C, Levinson M M, Love K, Joyce L D, DeVries W
Department of Medicine, Ohio State University, Columbus 43210.
JAMA. 1988 Feb 12;259(6):860-4.
This article describes the infectious complications that occurred among four of the longest-term recipients of the Jarvik-7 artificial heart. Infection arising from the drive lines, with spread to the mediastinal periprosthetic space, was the major limiting factor in long-term use of the device in these patients. Periprosthetic infections were due to coagulase-negative staphylococci, Staphylococcus aureus, Pseudomonas aeruginosa, and other Pseudomonas species. Other infectious complications incurred by some of the patients included pneumonia, empyema, urinary tract infection, and intravascular line sepsis with Candida. Intensive antimicrobial therapy for prolonged periods seemed to suppress but not to eradicate infection and was accompanied by the appearance of multiresistant bacterial strains. Complications of antimicrobial therapy included diarrhea secondary to overgrowth with Clostridium difficile in two patients. Use of the current device for more than 30 days should be considered extraordinary and should be reserved for patients for whom no other form of life support is available.
本文描述了接受Jarvik - 7型人工心脏的4位最长疗程患者所发生的感染并发症。由驱动线引发感染并扩散至纵隔人工心脏周围间隙,是这些患者长期使用该装置的主要限制因素。人工心脏周围感染是由凝固酶阴性葡萄球菌、金黄色葡萄球菌、铜绿假单胞菌和其他假单胞菌属引起的。部分患者发生的其他感染并发症包括肺炎、脓胸、尿路感染以及念珠菌所致的血管内导管败血症。长时间强化抗菌治疗似乎可抑制但无法根除感染,且会伴随多重耐药菌株的出现。抗菌治疗的并发症包括2例患者因艰难梭菌过度生长继发腹泻。使用当前这种装置超过30天应被视为特殊情况,且应仅保留给没有其他生命支持形式可用的患者。